RECOVERY Collaborative Group 2023, ' Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507 . https://doi.org/10.1016/S0140-6736(23)00510-X
Mumford, A D & Gibbison, B J J 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 Dimitriadis, G K 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 RECOVERY Collaborative Group & Dark, P 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet . https://doi.org/10.1016/S0140-6736(22)01109-6
Lancet (London, England) LANCET RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C & Dark, P 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7
RECOVERY Collaborative Group & Downey, D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', The Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Mumford, A D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Lancet (London, England) Group, RECOVERY C, Felton, T, Dark, P & Mathioudakis, A 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5
Hausenloy, D J, Kharbanda, R K, Møller, U K, Ramlall, M, Aarøe, J, Butler, R, Bulluck, H, Clayton, T, Dana, A, Dodd, M, Engstrom, T, Evans, R, Lassen, J F, Christensen, E F, Garcia-Ruiz, J M, Gorog, D A, Hjort, J, Houghton, R F, Ibanez, B, Knight, R, Lippert, F K, Lønborg, J T, Maeng, M, Milasinovic, D, More, R, Nicholas, J M, Jensen, L O, Perkins, A, Radovanovic, N, Rakhit, R D, Ravkilde, J, Ryding, A D, Schmidt, M R, Riddervold, I S, Sørensen, H T, Stankovic, G, Varma, M, Webb, I, Terkelsen, C J, Greenwood, J P, Yellon, D M, Bøtker, H E & CONDI-2/ERIC-PPCI Investigators 2019, ' Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI) : a single-blind randomised controlled trial ', Lancet, vol. 394, no. 10207, pp. 1415-1424 . https://doi.org/10.1016/S0140-6736(19)32039-2 Repisalud Instituto de Salud Carlos III (ISCIII) CONDI-2/ERIC-PPCI Investigators 2019, ' Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI) : a single-blind randomised controlled trial ', Lancet, vol. 394, no. 10207, pp. 1415-1424 . https://doi.org/10.1016/S0140-6736(19)32039-2 Hausenloy, D J, Kharbanda, R K, Møller, U K, Ramlall, M, Aarøe, J, Butler, R, Bulluck, H, Clayton, T, Dana, A, Dodd, M, Engstrom, T, Evans, R, Lassen, J F, Christensen, E F, Garcia-Ruiz, J M, Gorog, D A, Hjort, J, Houghton, R F, Ibanez, B, Knight, R, Lippert, F K, Lønborg, J T, Maeng, M, Milasinovic, D, More, R, Nicholas, J M, Jensen, L O, Perkins, A, Radovanovic, N, Rakhit, R D, Ravkilde, J, Ryding, A D, Schmidt, M R, Sørensen, H T, CONDI-2/ERIC-PPCI Investigators, Junker, A, Madsen, M, Christiansen, E H, Jakobsen, L, Carstensen, S, Kristensen, S D, Sørensen, R, Jensen, S E, Aziz, A, Hansen, H S, Ellert, J, Veien, K, Pedersen, K E, Hansen, K N, Ahlehoff, O, Giebner, M & Andersen, H R 2019, ' Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI) : a single-blind randomised controlled trial ', The Lancet, vol. 394, no. 10207, pp. 1415-1424 . https://doi.org/10.1016/S0140-6736(19)32039-2 Hausenloy, D J, Kharbanda, R K, Møller, U K, Ramlall, M, Aarøe, J, Butler, R, Bulluck, H, Clayton, T, Dana, A, Dodd, M, Engstrom, T, Evans, R, Lassen, J F, Christensen, E F, Garcia-Ruiz, J M, Gorog, D A, Hjort, J, Houghton, R F, Ibanez, B, Knight, R, Lippert, F K, Lønborg, J T, Maeng, M, Milasinovic, D, More, R, Nicholas, J M, Jensen, L O, Perkins, A, Radovanovic, N, Rakhit, R D, Ravkilde, J, Ryding, A D, Schmidt, M R, Riddervold, I S, Sørensen, H T, Stankovic, G, Varma, M, Webb, I, Terkelsen, C J, Greenwood, J P, Yellon, D M, Bøtker, H E, CONDI-2/ERIC-PPCI Investigators, Villadsen, A B, Raungaard, B, Thuesen, L, Christiansen, M K, Freeman, P, Jensen, S E & Skov, C S 2019, ' Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI) : a single-blind randomised controlled trial ', Lancet, vol. 394, no. 10207, pp. 1415-1424 . https://doi.org/10.1016/S0140-6736(19)32039-2
Europe PubMed Central Lancet (London, England) RECOVERY Collaborative Group & Downey, D 2022, ' Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', The Lancet, vol. 399, no. 10320, pp. 143-151 . https://doi.org/10.1016/S0140-6736(21)01825-0 Group, RECOVERY C & Dark, P 2022, ' Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 399, no. 10320, pp. 143-151 . https://doi.org/10.1016/S0140-6736(21)01825-0 Mumford, A D 2022, ' Aspirin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 399, no. 10320, pp. 143-151 . https://doi.org/10.1016/S0140-6736(21)01825-0